缅北禁地

I am a Senior Research Associate in the Health Economics Group, Population Health Sciences Institute with experience of working in academia and industry. 

My areas of expertise are systematic reviews of economic evaluations, within trial economic evaluations, economic modelling and preference elicitations (e.g. Discrete Choice Experiments, Contingent Valuation Methods). I am also interested in economic evaluations of global health issues and healthcare systems. 

As a member of 缅北禁地 Technology Assessment Group, I lead the critique of company submissions to NICE. I have experience of leading health economics element in Single Technology Appraisals (STAs), Multiple Technology Appraisals (MTAs), Late Stage Assessments (LSA) and Diagnostic Assessment Reviews (DARs).

Qualifications:

Doctor of Philosophy (PhD) 缅北禁地, United Kingdom 

MSc PH (Health Economics & Financial Management), Jagiellonian University, Krakow, Poland

Master of Public Health (MPH), University of Sheffield, United Kingdom

Bachelors in Public Health (BPH), Institute of Medicine, Tribhuvan University, Nepal

Previous Positions: 

Senior Research Consultant (Health Economics), Cytel (May 2022 to January 2023)

Associate Researcher (Health Economics), Health Economics Group, Population Health Sciences Institute, 缅北禁地 (June 2022 to February 2023)

Research Fellow (Health Economics), NIHR Applied Research Collaboration (ARC), North East and North Cumbria (NENC), 缅北禁地 upon Tyne, UK (November 2020 to May 2022)

Research Associate, Health Economics Group, Population Health Sciences Institute, 缅北禁地, UK (February 2019- May 2022)

Health Foundation Doctoral Research Fellow/ Research Assistant, Health Economics Group, Institute of Health & Society, 缅北禁地, UK (March 2014-February 2019)

Research Assistant, Health Economics and Health Technology Assessment (HEHTA) Team, University of Glasgow, UK (September 2013-February 2014)

Research Associate, Division of Health and Social Care Research, King’s College London, UK (April 2010-September 2013)

Research Officer, Public Health Network Office, NHS Cambridgeshire, UK (January 2009-April 2010)

Research Interests:

Economic evaluations of health interventions and health system changes; health outcome valuation; preference elicitations (example: the use of discrete choice experiments/contingent valuation methods), global health.

Some of the research projects I am/was involved in are:

• NIHR129196 - Adapted suicide safety plans to address self harm, suicidal ideation and suicide behaviours in autistic adults: an interventional single arm feasibility trial and external pilot randomised controlled trial - I lead on the health economics work package where feasibility and appropriateness of health economics tools is being assessed.
• European Commission under the H2020 programme Grant: MCDS-Therapy- Repurposing of carbamazepine for treatment of skeletal dysplasia- I lead on the Budget Impact Assessment of introducing carbamazepine and also contribute to the economic evaluation model assessing its cost-effectiveness.
• NIHR HSDR : A Real-World, In-Situ, Evaluation Of The Introduction And Scale-Up Of Robot-Assisted Surgical Services In The NHS: Evaluating Its Impact On Clinical And Service Delivery, Effectiveness And Cost (REINFORCE)]- I lead on the health economics work package where I am carrying out a within-trial analyses, economic modelling and a budget impact assessment.
• NIHR Technology Appraisal Review (TAR)- I lead on the Single and Multiple technology appraisals/diagnostics assessments as per NICE's requirements.
• NIHR ARC NENC open funding: Assessing the impact and cost-effectiveness of a community-centred approach to public health on mental health and well-being; a co-produced mixed methods study.- I lead on the health economics work package and conduct a controlled interrupted time series (ITS) analysis to assess the cost-effectiveness of the study intervention.

I lead sessions in MSc Data Science as one of the Health Economics Module Lecturers. I am actively involved in module planning, preparations and student markings.

My current supervisee are:

• Salamatu Abdul-Aziz (MD)
• Amira Al Zadjali (PhD)

My recent supervisee were: 

• Sonal Sharma (UG)
• Will King (MSc)
• Helen Grover (MD)

I also sit in progression panel of PhD/MD students.

• Articles

  • Bhattarai N, Goodwin J, Pelton M, Gordon I, Rodgers J, Cassidy S, Wagnild J, Wilson C, Heslop P, Ogundimu E, O'Connor R, Ramsay S, Townsend E, Vale L. . BMC Health Services Research 2025, 25, 473.
  • Sagoo GS, Clement ND, Gil-Rojas Y, Bhattarai N, Galloway S, Baron JB, Smith K, Weir DJ, Deehan DJ. . Bone and Joint Open 2025, 6(6), 658-666.
  • Kenny R, Bhattarai N, O'Connor N, Gonzalez-Moral SG, O'Keefe H, Hosseini-Jebeli S, Meader N, Rice S. . Health Technology Assessment 2025, 29(50), 1-160.
  • Goodwin J, Gordon I, O'Keeffe S, Carling S, Berresford A, Bhattarai N, Heslop P, Nielsen E, O'Connor RC, Ogundimu E, Pelton M, Ramsay SE, Rodgers J, Townsend E, Vale L, Wilson C, Cassidy S. . Autism in Adulthood 2025, 7(3), 293-302.
  • Rodgers J, Cassidy S, Pelton M, Goodwin J, Wagnild J, Bhattarai N, Gordon I, Wilson C, Heslop P, Ogundimu E, O'Connor RC, Ramsay SE, Townsend E, Vale L. . eClinicalMedicine 2024, 73, 102662.
  • Rodgers J, Goodwin J, Nielsen E, Bhattarai N, Heslop P, Kharatikoopaei E, O'Connor RC, Ogundimu E, Ramsay SE, Steele K, Townsend E, Vale L, Walton E, Wilson C, Cassidy S. . Pilot and Feasibility Studies 2023, 9, 31.
  • Grover H, King W, Bhattarai N, Moloney E, Sharp L, Fuller L. . Lung Cancer 2022, 170, 20-33.
  • Price CI, White P, Balami J, Bhattarai N, Coughlan D, Exley C, Flynn D, Halvorsrud K, Lally J, McMeekin P, Shaw L, Snooks H, Vale L, Watkins A, Ford GA. . Programme Grants for Applied Research 2022, 10(4).
  • Cucato G, Snowden C, McCone E, Nesbitt C, Nandhra S, Fong M, Kaner E, Rowland M, Bhattarai N, Court P, Bell O, Saxton JM, Prentis J. . PLoS ONE 2022, 17(6), e0269999.
  • Hill SR, Bhattarai N, Tolley CL, Slight SP, Vale L. . BMJ Open 2022, 12(2), e053115.
  • Bhattarai N, Price CI, McMeekin P, Javanbakht M, Vale L, Ford GA, Shaw L. . International Journal of Stroke 2022, 17(3), 282-290.
  • Brocklehurst P, Hoare Z, Woods C, Williams L, Brand A, Shen J, Breckons M, Ashley J, Jenkins A, Gough L, Preshaw P, Burton C, Shepherd K, Bhattarai N. . Health Services and Delivery Research 2021, 9(3).
  • Bhattarai N, Mason H, Kernohan A, Poole M, Bamford C, Robinson L, Vale L. . International Journal of Geriatric Psychiatry 2020, 35(5), 489-497.
  • Flynn D, Moloney E, Bhattarai N, Scott J, Breckons M, Avery L, Moy N. . Health Policy and Technology 2020, 9(4), 673-691.
  • Shaw L, Bhattarai N, Cant R, Drummond A, Ford GA, Forster A, Francis R, Hills K, Howel D, Lavery AM, McKevitt C, Price C, Stamp E, Stevens E, Vale L, Rodgers H. . Health Technology Assessment 2020, 24(24).
  • Shaw L, Bhattarai N, Cant R, Drummond A, Ford GA, Forster A, Francis R, Hills K, Howel D, Laverty AM, McKevitt C, McMeekin P, Price C, Stamp E, Stevens E, Vale L, Rodgers H. . Health Technology Assessment 2020, 24(24), 1-202.
  • Bhattarai N, McMeekin P, Price CI, Vale L. . BMJ Open 2019, 9(11), e030966.
  • Rodgers H, Howel D, Bhattarai N, Cant R, Drummond A, Ford GA, Forster A, Francis R, Hills K, Laverty A-M, McKevitt C, McMeekin P, Price CIM, Stamp E, Stevens E, Vale L, Shaw L. . Stroke 2019, 50(12), 3561-3568.
  • Gulliford M, Charlton J, Bhattarai N, Rudisill C. . Journal of Public Health 2014, 36(4), 674-683.
  • Gulliford MC, Charlton J, Bhattarai N, Charlton C, Rudisill C. . The European Journal of Health Economics 2014, 15(4), 341-351.
  • Gulliford MC, Bhattarai N, Charlton J, Rudisill C. . Cost Effectiveness and Resource Allocation 2014, 12(4).
  • Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Prevalence of depression and utilization of health care in single and multiple morbidity: a population-based cohort study. Psychological Medicine. Psychological Medicine 2013, 43(7), 1423-31.
  • Charlton J, Rudisill C, Bhattarai N, Gulliford M. Impact of deprivation on occurrence, outcomes and health care costs of people with multiple morbidity. Journal of Health Services Research & Policy 2013, 18(4), 215-23.
  • Bhattarai N, Prevost AT, Wright AJ, Charlton J, Rudisill C, Gulliford MC. . BMC Public Health 2013, 13, 1203.
  • Bhattarai N, Charlton J, Rudisill C, Gulliford MC. . PLoS ONE 2012, 7(1), e29776.

• Note

  • Rodgers J, Cassidy S, Pelton M, Goodwin J, Nielsen E, Wagnild J, Bhattarai N, Gordon I, Wilson C, Heslop P, Ogundimu E, O'Connor RC, Ramsay SE, Townsend E, Vale L. . eClinicalMedicine 2025, 84(103260).

• Reports

  • Kenny R, Bhattarai N, O'Connor N, Garcia-Gonzalez S, O'Keefe H, Hosseini-Jebeli S, Meader N, Rice S. . Manchester: National Institute for Health and Care Excellence, 2024. Diagnostics guidance DG61.
  • Robinson L, Poole M, McLellan E, Lee R, Amador S, Bhattarai N, Bryant A, Coe D, Corbett A, Exley C, Goodman C, Gotts Z, Harrison-Dening K, Hill S, Howel D, Hrisos S, Hughes J, Kernohan A, Macdonald A, Mason H, Massey C, Neves S, Paes P, Rennie K, Rice S, Robinson T, Sampson E, Tucker S, Tzelis D, Vale L, Bamford C. . National Institute for Health Research, 2020. 8.

• Reviews

  • Turner RR, Coupe N, Griffiths S, Cheng K, Byrne-Davis L, Shallcross L, Hart J, Rice S, Shabaninejad H, Meader N, Bhattarai N, Lorencatto F. . Antimicrobial Resistance and Infection Control 2026, 15(1), 10.
  • Abdul-Aziz S, Bhattarai N, Vale L, Sagoo GS, Mukhopadhyay A. . Gynecologic Oncology Reports 2025, 57, 101680.
  • Bhattarai N, McMeekin P, Price C, Vale L. . BMJ Open 2016, 6(5), e011214.